These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8093135)

  • 1. Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study.
    Lynch A; Marlar R; Murphy J; Davila G; Santos M; Rutledge J; Emlen W
    Ann Intern Med; 1994 Mar; 120(6):470-5. PubMed ID: 8093135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome.
    Simchen MJ; Dulitzki M; Rofe G; Shani H; Langevitz P; Schiff E; Pauzner R
    Acta Obstet Gynecol Scand; 2011 Dec; 90(12):1428-33. PubMed ID: 21729009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes.
    Yelnik CM; Porter TF; Branch DW; Laskin CA; Merrill JT; Guerra MM; Lockshin MD; Buyon JP; Petri M; Sammaritano LR; Stephenson MD; Kim MY; Salmon JE
    Arthritis Rheumatol; 2016 Aug; 68(8):1964-9. PubMed ID: 26990620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies.
    Chauleur C; Galanaud JP; Alonso S; Cochery-Nouvellon E; Balducchi JP; Marès P; Fabbro-Peray P; Gris JC
    J Thromb Haemost; 2010 Apr; 8(4):699-706. PubMed ID: 20088936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies.
    Fredi M; Andreoli L; Aggogeri E; Bettiga E; Lazzaroni MG; Le Guern V; Lojacono A; Morel N; Piette JC; Zatti S; Costedoat-Chalumeau N; Tincani A
    Front Immunol; 2018; 9():864. PubMed ID: 29867924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preconception antiphospholipid antibodies and risk of subsequent early pregnancy loss.
    Gibbins KJ; Mumford SL; Sjaarda LA; Branch DW; Perkins NJ; Ye A; Schisterman EF; Silver RM
    Lupus; 2018 Aug; 27(9):1437-1445. PubMed ID: 29771194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of fifty-three consecutive calcium heparin treated pregnancies in patients with antiphospholipid antibody-related fetal loss.
    Ruffatti A; Orsini A; Di Lenardo L; Nardelli GB; Patrassi GM; Truscia D; Brigato G; Grella P; Todesco S
    Clin Exp Rheumatol; 1997; 15(5):499-505. PubMed ID: 9307857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent antiphospholipid antibodies do not contribute to adverse pregnancy outcomes.
    Soh MC; Pasupathy D; Gray G; Nelson-Piercy C
    Rheumatology (Oxford); 2013 Sep; 52(9):1642-7. PubMed ID: 23681394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry').
    Erton ZB; Sevim E; de Jesús GR; Cervera R; Ji L; Pengo V; Ugarte A; Andrade D; Andreoli L; Atsumi T; Fortin PR; Gerosa M; Zuo Y; Petri M; Sciascia S; Tektonidou MG; Aguirre-Zamorano MA; Branch DW; Erkan D;
    Lupus Sci Med; 2022 Jun; 9(1):. PubMed ID: 35701043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of postpartum thrombosis and preterm delivery in women with antiphospholipid antibodies and recurrent pregnancy loss.
    Clark CA; Spitzer KA; Crowther MA; Nadler JN; Laskin MD; Waks JA; Laskin CA
    J Rheumatol; 2007 May; 34(5):992-6. PubMed ID: 17407219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
    Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between antiphospholipid antibodies and first-trimester spontaneous abortion: prospective study of pregnancies detected within 21 days of conception.
    Simpson JL; Carson SA; Chesney C; Conley MR; Metzger B; Aarons J; Holmes LB; Jovanovic-Peterson L; Knopp R; Mills JL
    Fertil Steril; 1998 May; 69(5):814-20. PubMed ID: 9591485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The concentrations of bile acids and erythropoietin in pregnant women with intrahepatic cholestasis and the state of the fetus and newborn.
    Kowalska-Kańka A; Maciejewski T; Niemiec KT
    Med Wieku Rozwoj; 2013; 17(3):232-45. PubMed ID: 24296447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcome. Influence of antiphospholipid antibody titer, prior pregnancy losses and treatment.
    Reece EA; Garofalo J; Zheng XZ; Assimakopoulos E
    J Reprod Med; 1997 Jan; 42(1):49-55. PubMed ID: 9018646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes.
    Yamada H; Atsumi T; Kobashi G; Ota C; Kato EH; Tsuruga N; Ohta K; Yasuda S; Koike T; Minakami H
    J Reprod Immunol; 2009 Jan; 79(2):188-95. PubMed ID: 19211151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study.
    Del Ross T; Ruffatti A; Visentin MS; Tonello M; Calligaro A; Favaro M; Hoxha A; Punzi L
    J Rheumatol; 2013 Apr; 40(4):425-9. PubMed ID: 23418380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pregnancy outcome in 54 patients with antiphospholipid syndrome: a retrospective clinical study].
    Zheng XJ; Deng XL; Liu XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Apr; 46(2):323-8. PubMed ID: 24743831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prophylaxis to prevent obstetric complications in asymptomatic women with antiphospholipid antibodies: a systematic review.
    Amengual O; Fujita D; Ota E; Carmona L; Oku K; Sugiura-Ogasawara M; Murashima A; Atsumi T
    Lupus; 2015 Oct; 24(11):1135-42. PubMed ID: 25813871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.